PulseAugur
LIVE 14:00:05
research · [1 source] ·
0
research

Paradigm uses GPT-4 to improve clinical trial patient matching accuracy

Paradigm, a healthcare technology company, has partnered with OpenAI to improve patient access to clinical trials. By integrating GPT-4 into their platform, Paradigm has significantly enhanced their ability to match patients with suitable trials, overcoming previous limitations of traditional ML models. This integration has led to a substantial increase in accuracy, a reduction in the time and resources needed for data evaluation, and has accelerated Paradigm's ability to expand its services. AI

Summary written by gemini-2.5-flash-lite from 1 source. How we write summaries →

RANK_REASON This is a case study detailing the application of an existing model (GPT-4) to a specific domain (healthcare) and reporting on its performance improvements, fitting the description of a research or application paper.

Read on OpenAI News →

Paradigm uses GPT-4 to improve clinical trial patient matching accuracy

COVERAGE [1]

  1. OpenAI News TIER_1 Italiano(IT) ·

    Using AI to improve patient access to clinical trials

    Paradigm uses OpenAI’s API to improve patient access to clinical trials.